STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS
The estimated number of DR TB patients in Indonesia is increasing. High adverse drug reactions have the potential to affect the success of DR TB patient treatment. Linezolid is one of the drugs in combination with DR TB therapy that has the potential to cause adverse drug reactions in the form of h...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Universitas Muhammadiyah Magelang
2025-06-01
|
| Series: | Jurnal Farmasi Sains dan Praktis |
| Subjects: | |
| Online Access: | https://journal.unimma.ac.id/index.php/pharmacy/article/view/12472 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849716676540497920 |
|---|---|
| author | Rinto Susilo Elza Sundhani Indah Setyaningsih Ririn Retnaningsih Ucu Nurjanah Nok Endang Ayu Prihatini |
| author_facet | Rinto Susilo Elza Sundhani Indah Setyaningsih Ririn Retnaningsih Ucu Nurjanah Nok Endang Ayu Prihatini |
| author_sort | Rinto Susilo |
| collection | DOAJ |
| description |
The estimated number of DR TB patients in Indonesia is increasing. High adverse drug reactions have the potential to affect the success of DR TB patient treatment. Linezolid is one of the drugs in combination with DR TB therapy that has the potential to cause adverse drug reactions in the form of hematological disorders and visual impairment. This study aims to determine the incidence of Linezolid ADRs, including the incidence, severity, and risk factors associated with the occurrence of ADRs. This type of study is observational with a cross-sectional design conducted retrospectively in DR TB patients at the lung clinic of Hospital 'X" and Hospital "Y" in Indonesia. The results of the study showed that the incidence of ADRs suspected of Linezolid that met the criteria was 70 patients out of a total of 215. The most common type of ADRs was hematological disorders at 89%, the rest were visual impairment. The type of regimen and type of ADRs correlate with the severity of ADRs. It is necessary to monitor drug levels in the blood in order to monitor and prevent the potential for more severe ADRs so that therapy can be individualized.
|
| format | Article |
| id | doaj-art-306b2fb404da4d72a7269a15ec2b58d1 |
| institution | DOAJ |
| issn | 2549-9068 2579-4558 |
| language | Indonesian |
| publishDate | 2025-06-01 |
| publisher | Universitas Muhammadiyah Magelang |
| record_format | Article |
| series | Jurnal Farmasi Sains dan Praktis |
| spelling | doaj-art-306b2fb404da4d72a7269a15ec2b58d12025-08-20T03:12:56ZindUniversitas Muhammadiyah MagelangJurnal Farmasi Sains dan Praktis2549-90682579-45582025-06-0111210.31603/pharmacy.v11i2.12472STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTSRinto Susilo0Elza Sundhani1Indah Setyaningsih2Ririn Retnaningsih3Ucu Nurjanah4Nok Endang Ayu Prihatini5Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Ahmad Dahlan Cirebon, Cirebon, Indonesia, 45141Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Purwokerto, Indonesia, 53111Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Ahmad Dahlan Cirebon, Cirebon, Indonesia, 45141Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Purwokerto, Indonesia, 53111Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Purwokerto, Purwokerto, Indonesia, 53111Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Muhammadiyah Ahmad Dahlan Cirebon, Cirebon, Indonesia, 45141 The estimated number of DR TB patients in Indonesia is increasing. High adverse drug reactions have the potential to affect the success of DR TB patient treatment. Linezolid is one of the drugs in combination with DR TB therapy that has the potential to cause adverse drug reactions in the form of hematological disorders and visual impairment. This study aims to determine the incidence of Linezolid ADRs, including the incidence, severity, and risk factors associated with the occurrence of ADRs. This type of study is observational with a cross-sectional design conducted retrospectively in DR TB patients at the lung clinic of Hospital 'X" and Hospital "Y" in Indonesia. The results of the study showed that the incidence of ADRs suspected of Linezolid that met the criteria was 70 patients out of a total of 215. The most common type of ADRs was hematological disorders at 89%, the rest were visual impairment. The type of regimen and type of ADRs correlate with the severity of ADRs. It is necessary to monitor drug levels in the blood in order to monitor and prevent the potential for more severe ADRs so that therapy can be individualized. https://journal.unimma.ac.id/index.php/pharmacy/article/view/12472Adverse Drug ReactionsLinezolidDR TB |
| spellingShingle | Rinto Susilo Elza Sundhani Indah Setyaningsih Ririn Retnaningsih Ucu Nurjanah Nok Endang Ayu Prihatini STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS Jurnal Farmasi Sains dan Praktis Adverse Drug Reactions Linezolid DR TB |
| title | STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS |
| title_full | STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS |
| title_fullStr | STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS |
| title_full_unstemmed | STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS |
| title_short | STUDY OF ADVERSE DRUG REACTIONS OF LINEZOLID IN DRUG RESISTANT TUBERCULOSIS PATIENTS |
| title_sort | study of adverse drug reactions of linezolid in drug resistant tuberculosis patients |
| topic | Adverse Drug Reactions Linezolid DR TB |
| url | https://journal.unimma.ac.id/index.php/pharmacy/article/view/12472 |
| work_keys_str_mv | AT rintosusilo studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients AT elzasundhani studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients AT indahsetyaningsih studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients AT ririnretnaningsih studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients AT ucunurjanah studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients AT nokendangayuprihatini studyofadversedrugreactionsoflinezolidindrugresistanttuberculosispatients |